(Press-News.org) Researchers at the University of St Andrews have uncovered a long‑elusive molecular ‘reshuffle', a breakthrough that tackles one of chemistry’s most persistent challenges and could transform the way medicines are manufactured.
In a paper published today (6th January) in Nature Chemistry, researchers from the School of Chemistry have found a key to unlocking an 80-year-old chemical puzzle, which could have important ramifications for fine chemical processes like those involved in the manufacture of medicines.
Chiral molecules are asymmetric or non-superimposable on their mirror image. Each side is different, existing in “right hand” and “left hand” forms. Often only one of these “handed” forms has the desired chemical or biological activity, while the other may have unwanted side effects.
Using a combination of lab experiments and quantum chemistry calculations, researchers have now discovered a new way to control the handedness of a notoriously difficult chemical process, known as the ‘[1,2]-Wittig rearrangement’ that will impact on how scientists design selective chemical reactions, such as those used in pharmaceutical production or advanced materials.
First discovered over 80 years ago, this process selectively reorganizes atoms within a molecule but was traditionally considered too unpredictable to control, making it almost impossible to use.
However, researchers from St Andrews working alongside colleagues at the University of Bath, discovered that a catalyst first steers the molecule through an initial asymmetric rearrangement that sets its ‘handedness’, that is followed by a previously unrecognized molecular reshuffle that maintains molecular chirality.
Lead author of the paper, Professor Andrew Smith from the University of St Andrews, said: “This discovery represents a fundamental shift in how we understand and control stereochemistry in rearrangement reactions.”
Co-lead Dr Matthew Grayson from the University of Bath, added: “Our findings open the door to new asymmetric transformations based on mechanistic pathways that chemists previously dismissed as inaccessible.”
This discovery will pave the way for faster, cleaner, and more selective ways to make complex molecules of a single handedness, with applications ranging from new drugs to advanced materials.
END
Scientists discover molecular ‘reshuffle’ and crack an 80-year-old conundrum
Researchers at the University of St Andrews have uncovered a long‑elusive molecular ‘reshuffle,’ a breakthrough that tackles one of chemistry’s most persistent challenges and could transform the way medicines are manufactured.
2026-01-06
ELSE PRESS RELEASES FROM THIS DATE:
How stressors during pregnancy impact the developing fetal brain
2026-01-06
The maternal microbiome and immune system have both independent and synergistic effects on fetal brain health - changes in the mother’s immune system have been linked to an increased risk of neurodevelopmental disorders in children. A new study, published today in Nature Neuroscience, expands our understanding of this “gut-immune axis” by mapping the impact of stressors during pregnancy – namely changes in the microbiome and activation of the immune system - on the neuroimmune landscape of the developing fetal brain.
The research team, led by ...
Electrons lag behind the nucleus
2026-01-06
One of the great successes of 20th-century physics was the quantum mechanical description of solids. This allowed scientists to understand for the first time how and why certain materials conduct electric current and how these properties could be purposefully modified. For instance, semiconductors such as silicon could be used to produce transistors, which revolutionized electronics and made modern computers possible.
To be able to mathematically capture the complex interplay between electrons and atomic nuclei and their motions in a solid, physicists ...
From fungi to brain cells: one scientist's winding path reveals how epigenomics shapes neural destiny
2026-01-06
LA JOLLA, California, USA, 6 January 2026 -- In a revealing Genomic Press Interview published today in Genomic Psychiatry, Dr. Maria Margarita Behrens recounts an extraordinary scientific journey that wound through four countries and multiple disciplines before arriving at fundamental questions about how the brain develops and what goes wrong in psychiatric disorders. Her work now stands at the forefront of international efforts to decode the molecular signatures that define every cell type in the human brain.
Dr. Behrens serves as a faculty member in the Computational Neurobiology Laboratory at the Salk Institute for Biological Studies and holds ...
Schizophrenia and osteoporosis share 195 genetic loci, highlighting unexpected biological bridges between brain and bone
2026-01-06
TIANJIN, CHINA, 6 January 2026 -- A comprehensive genetic investigation led by Dr. Feng Liu at Tianjin Medical University General Hospital has uncovered striking molecular connections between schizophrenia and bone health, identifying 195 shared genetic loci that may explain why psychiatric patients face elevated fracture risks. The peer-reviewed research, published in Genomic Psychiatry, analyzed genomic data from over half a million individuals and reveals that these two seemingly unrelated conditions suggest overlapping biological pathways at the molecular level.
The finding carries immediate clinical weight. Patients with schizophrenia experience osteoporosis at rates far ...
Schizophrenia-linked genetic variant renders key brain receptor completely unresponsive to both natural and therapeutic compounds
2026-01-06
ADELAIDE, South Australia, AUSTRALIA, 6 January 2026 -- A genetic mutation passed from mother to children in families affected by schizophrenia has now been shown to completely silence a brain receptor that pharmaceutical companies are racing to target with new drugs. Researchers at Flinders University, publishing their peer-reviewed findings in Genomic Psychiatry, demonstrate that this single amino acid change transforms the trace amine-associated receptor 1 (TAAR1) from a functioning cellular gatekeeper into a molecular dead end.
The discovery carries weight far beyond basic science. Several drug companies have invested heavily in TAAR1-targeting medications, ...
Innovative review reveals overlooked complexity in cellular energy sensor's dual roles in Alzheimer's disease
2026-01-06
WINSTON-SALEM, North Carolina, USA, 6 January 2026 -- A comprehensive mini-review published today after peer review in Brain Medicine by Dr. Tao Ma and colleagues at Wake Forest University School of Medicine synthesizes emerging evidence that two isoforms of a critical cellular energy sensor play distinct, and sometimes opposing, roles in Alzheimer's disease. The analysis proposes that this overlooked complexity may explain why pharmacological approaches targeting AMP-activated protein kinase have yielded frustratingly mixed results in treating the disease that ...
Autism research reframed: Why heterogeneity is the data, not the noise
2026-01-06
KODAIRA, Tokyo, JAPAN, 6 January 2026 -- In a revealing Genomic Press Interview published today in Genomic Psychiatry, Dr. Noritaka Ichinohe challenges a foundational assumption that has quietly constrained psychiatric research for decades: the belief that meaningful explanation requires averaging away individual differences. His three decades of translational neuroscience across Japanese research institutions have instead demonstrated that biological heterogeneity, far from being statistical noise to eliminate, constitutes the very phenomenon demanding ...
Brazil's genetic treasure trove: supercentenarians reveal secrets of extreme human longevity
2026-01-06
SÃO PAULO, SP, BRAZIL, 6 January 2026 -- A Viewpoint published today in Genomic Psychiatry by Dr. Mayana Zatz and colleagues at the Human Genome and Stem Cell Research Center, University of São Paulo, examines why Brazil represents one of the most valuable yet underutilized resources for understanding extreme human longevity. The synthesis draws upon the team's ongoing research with a nationwide cohort of long-lived individuals while contextualizing recent advances in supercentenarian biology.
Where Genetic Diversity Meets Exceptional Aging
Why do some humans live ...
The (metabolic) cost of life
2026-01-06
There are “costs of life” that mechanical physics cannot calculate. A clear example is the energy required to keep specific biochemical processes active — such as those that make up photosynthesis, although the examples are countless — while preventing alternative processes from occurring. In mechanics, no displacement implies zero work, and, put simply, there is no energetic cost for keeping things from happening. Yet careful stochastic thermodynamic calculations show that these costs do exist — and they are often quite significant.
A ...
CFRI special issue call for papers: New Frontiers in Sustainable Finance
2026-01-06
China Finance Review International (CFRI) has announced a call for papers for a forthcoming special issue titled “New Frontiers in Sustainable Finance,” inviting original research that examines the growing role of sustainability in financial markets, corporate decision-making, and regulatory frameworks. The special issue aims to capture recent advances in sustainable finance as environmental, social, and governance (ESG) considerations become increasingly central to the global ...
LAST 30 PRESS RELEASES:
NSF–DOE Vera C. Rubin Observatory spots record-breaking asteroid in pre-survey observations
Ribosomal engineering creates “super-probiotic” bacteria
This self-powered eye tracker harnesses energy from blinking and is as comfortable as everyday glasses
Adverse prenatal exposures linked to higher rates of mental health issues, brain changes in adolescents
Restoring mitochondria shows promise for treating chronic nerve pain
Nature study identifies a molecular switch that controls transitions between single-celled and multicellular forms
USU chemists' CRISPR discovery could lead to single diagnostic test for COVID, flu, RSV
Early hominins from Morocco reveal an African lineage near the root of Homo sapiens
Small chimps, big risks: What chimps show us about our own behavior
We finally know how the most common types of planets are created
Thirty-year risk of cardiovascular disease among healthy women according to clinical thresholds of lipoprotein(a)
Yoga for opioid withdrawal and autonomic regulation
Gene therapy ‘switch’ may offer non-addictive pain relief
Study shows your genes determine how fast your DNA mutates with age
Common brain parasite can infect your immune cells. Here's why that's probably OK
International experts connect infections and aging through cellular senescence
An AI–DFT integrated framework accelerates materials discovery and design
Twist to reshape, shift to transform: Bilayer structure enables multifunctional imaging
CUNY Graduate Center and its academic partners awarded more than $1M by Google.org to advance statewide AI education through the Empire AI consortium
Mount Sinai Health system receives $8.5 million NIH grant renewal to advance research on long-term outcomes in children with congenital heart disease
Researchers develop treatment for advanced prostate cancer that could eliminate severe side effects
Keck Medicine of USC names Christian Pass chief financial officer
Inflatable fabric robotic arm picks apples
MD Anderson and SOPHiA GENETICS announce strategic collaboration to accelerate AI-driven precision oncology
Oil residues can travel over 5,000 miles on ocean debris, study finds
Korea University researchers discover that cholesterol-lowering drug can overcome chemotherapy resistance in triple-negative breast cancer
Ushikuvirus: A newly discovered giant virus may offer clues to the origin of life
Boosting the cell’s own cleanup
Movement matters: Light activity led to better survival in diabetes, heart, kidney disease
Method developed to identify best treatment combinations for glioblastoma based on unique cellular targets
[Press-News.org] Scientists discover molecular ‘reshuffle’ and crack an 80-year-old conundrumResearchers at the University of St Andrews have uncovered a long‑elusive molecular ‘reshuffle,’ a breakthrough that tackles one of chemistry’s most persistent challenges and could transform the way medicines are manufactured.